Posts in Category: medicaid

GAO Issues Report Criticizing HHS’ Oversight of 340B Duplicate Discounts

On January
27, 2020, the U.S. Government Accountability Office (GAO) released a report (the Report) assessing oversight
by the Department of Health and Human Services (HHS) of

31 Jan 2020

CMS Issues Informational Bulletin on State Duplicate Discount Practices

On January
8, 2020, the Centers for Medicare & Medicaid Services (CMS) issued an Informational Bulletin (Bulletin) outlining CMS’s view of
current “best practices” by states to

13 Jan 2020

Senate Finance Committee Approves Major Drug Pricing Bill

On Thursday, July 25, 2019, the Senate Finance Committee voted to approve a wide-ranging drug pricing bill, the Prescription Drug Pricing Reduction Act (PDPRA) of

25 Jul 2019

Final Rule Will Require Drug Manufacturers to Disclose Prices in TV Advertisements

Earlier today, HHS issued a Final Rule that will require pharmaceutical manufacturers to disclose the wholesale acquisition cost (“WAC”) in direct-to-consumer TV advertisements for all

8 May 2019

California Medicaid Will Transition All Pharmacy Services to Fee-for-Service

On January 7, California Gov. Gavin Newsom signed an executive order instructing Medi-Cal to transition all pharmacy services for Medi-Cal managed care to fee-for-service (FFS)

11 Jan 2019

CMS Finalizes Part B Cuts for 340B Drugs

CMS finalized yesterday a nearly 30 percent cut in Medicare Part B reimbursement to hospitals for 340B physician-administered drugs.  The payment cut will go into

2 Nov 2017

CMS Releases Covered Outpatient Drug Rule; Clarifies 340B in Managed Care

The Centers for Medicare and Medicaid Services (CMS) issued its long awaited regulations on Medicaid reimbursement and rebates for so-called “covered outpatient drugs” today.  The rule is

1 Feb 2016